about
Comparison of dermoscopy and reflectance confocal microscopy for the diagnosis of malignant skin tumours: a meta-analysis.Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic ApproachesA meta-analysis of reflectance confocal microscopy for the diagnosis of malignant skin tumours.'This isn't what mine looked like': a qualitative study of symptom appraisal and help seeking in people recently diagnosed with melanoma.The European approach to in-transit melanoma lesions.Childhood Body Size and the Risk of Malignant Melanoma in AdulthoodEffect of low frequency magnetic fields on melanoma: tumor inhibition and immune modulationEpidemiological trends in skin cancer.The role of spectrophotometry in the diagnosis of melanoma.PPARbeta activation inhibits melanoma cell proliferation involving repression of the Wilms' tumour suppressor WT1.Increasing burden of melanoma in the United States.Trends in skin cancer incidence by socioeconomic position in Scotland, 1978-2004Vitamin A intake and risk of melanoma: a meta-analysisMalignant melanoma: a pictorial review.A reliable method for the selection of exploitable melanoma archival paraffin embedded tissues for transcript biomarker profilingThe role of skin self-examination at the Swiss skin cancer day.Epidemiology of invasive cutaneous melanoma.Up-regulation of hepatoma-derived growth factor facilitates tumor progression in malignant melanoma [corrected]Immunotoxins: a promising treatment modality for metastatic melanoma?New malignancies after squamous cell carcinoma and melanomas: a population-based study from NorwayThe biography of the immune system and the control of cancer: from St Peregrine to contemporary vaccination strategies.Melanocortin 1 receptor genotype: an important determinant of the damage response of melanocytes to ultraviolet radiation.13. Cancers attributable to solar (ultraviolet) radiation exposure in the UK in 2010.Melanoma treatment costs: a systematic review of the literature, 1990-2011Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011.Do we need a revised public health policy on sun exposure?Melanoma incidence and mortality in Scotland 1979-2003.Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003.Parental Use and Educational Campaigns on Sunbed Use Among Teenagers and Adolescents.Modification of second cancer risk after malignant melanoma by parental history of cancer.The impact of comorbidity and stage on prognosis of Danish melanoma patients, 1987-2009: a registry-based cohort studyCurrent clinical overview of cutaneous melanoma.Associations between childhood height and morphologically different variants of melanoma in adulthood.Cellular and sub-cellular responses to UVA in relation to carcinogenesis.Burden of skin diseases.Phenotyping of human melanoma cells reveals a unique composition of receptor targets and a subpopulation co-expressing ErbB4, EPO-R and NGF-R.Age-specific acceleration in malignant melanomaYears of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature.New developments in melanoma: utility of ultrasound imaging (initial staging, follow-up and pre-SLNB).
P2860
Q30235299-0947177B-798E-45B1-9CD7-CE9F1A4FF798Q30238649-FBC0741C-1A45-4EDA-8B54-76B3F97AE2B4Q30250082-A17E010A-692C-405E-AFB8-D2CABF63ACFFQ30585721-B4C1425E-850F-4D65-B77C-5ED17A46D9B9Q33327121-E666F69B-20F0-4AD7-9C85-F7CC9592B691Q33571911-6BBA29DC-1FAA-4001-8B98-C9C927031501Q33642794-B2CBE0EB-B7EA-4C39-9F89-6EF6670E5219Q33655972-2DE9CEF1-A49B-4349-9AF1-9D89028FB4A5Q33657461-8CE4C36D-8D25-41EB-AC15-0440DFC019CFQ33742630-A0A0B06E-01A6-4DCF-A38C-5D15ACDEF707Q33836015-D4793FC5-510C-4F35-B7B3-3EC4A741CE55Q33903710-C264AE37-D375-47C0-B07B-9D76AE88E8C5Q33927933-0EAA7AE3-657D-4D8E-B2DA-46DC711E9B70Q33960191-38E12057-6E49-4C5F-896F-1AEC89C9F8B3Q34137281-190BB953-C59D-40AF-A934-035875632CAEQ34544182-AF6BCF74-07EB-49D8-B5ED-0D64E105D835Q34610057-D1C56107-054F-4E8E-BFC9-E03D0BFB1294Q34639683-051AD391-00EE-416C-8327-9FE6D6FB29A5Q34986254-A8478F0D-0D04-4920-BA03-50121D6BFAB4Q35124575-A345500D-59BE-46DD-8ED0-1AAD6028BA4AQ35226092-D615A540-84AE-4A5A-90BB-923DFD10C0DCQ35588847-1FD86F4F-4BE6-41A2-AD2E-4AEB79F769F3Q35654696-EB04DC5D-2406-4A6E-AD5D-4C5F920AF27EQ35831506-39D5D3C8-30A6-40FF-8CCD-5B71B8A40EE6Q35880909-F9078610-F767-4E06-94FF-367FE6693749Q36213647-D9B9DFEE-B89A-4AE3-95C8-29C84ADDBADDQ36480603-2F13E538-8881-45F1-948A-C5F2157E7657Q36609511-9E4CBF15-4781-45CA-AC94-242BA982175BQ36611532-37BBFC96-45D5-435A-B88B-390725BC06D1Q36822728-71CCDB10-178E-4C1E-B613-E66240CE2E62Q36858069-674390C1-1FFF-484A-B443-72FDEAD4FAE3Q37003327-A7ADAC66-60DC-46E2-AAF4-73F58B6F72ABQ37139142-B552ADEC-DF35-4902-B209-2B7E280F6173Q37347960-C10F1C49-AF19-45D4-A546-AF5B1F239CDBQ37417605-40CE0727-8954-430F-ACB0-1CEFFDD4296FQ37519631-EA935E6E-C46B-4203-B4B3-9AF5E05F8B11Q37529231-97AB7810-ED9F-4F49-8DA1-FB2862832697Q37738635-20F46343-7B1A-4384-8D5B-8EE3AA7B7D18Q37918528-07C2C26A-8110-4B44-B897-D25C913447EFQ37952237-366BC3ED-8C70-4567-A544-ED15620BB8B0
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Cutaneous malignant melanoma in Europe.
@en
type
label
Cutaneous malignant melanoma in Europe.
@en
prefLabel
Cutaneous malignant melanoma in Europe.
@en
P1476
Cutaneous malignant melanoma in Europe
@en
P2093
Jan Willem Coebergh
P304
P356
10.1016/J.EJCA.2004.06.003
P577
2004-11-01T00:00:00Z